Bolaideli: Reimagining China’s pet biopharmaceutical landscape through original, innovative research.

2026-07-13

Bolaideli: Reimagining China’s pet biopharmaceutical landscape through original, innovative research.

From the world’s first bovine serum albumin injection for dogs, Bosengjian®, to the Miao Beihu® feline trivalent vaccine, which has surpassed 5.5 million doses in total batch releases just 2.5 years after launch, and further to a portfolio of pioneering biologics currently under development, Taizhou Bolaideli Biotechnology Co., Ltd. (hereinafter referred to as Bolaideli) has forged an original‑innovation path—“from zero to one”—for Chinese pet‑pharmaceutical companies.

Learn more  

Ten Years of Steadfast Dedication, Qingdao Medical University Reaches New Heights

2026-02-27

Ten Years of Steadfast Dedication, Qingdao Medical University Reaches New Heights

The 17th East–West Small Animal Clinical Veterinarians Conference Grandly Presents the Bolaideli Outstanding Young Veterinarian Award

Learn more